NFKB1 and acute myeloid leukemia: Given that the malignant cells thrive under oxidant stress that switches OGG1 to an NFκB-augmenting factor, the inhibition of this circuit by the compound TH5487 would hamper the interaction of AML cells with their microenvironment [152].